To create quality products & consistent experiences, we leverage decades of combined research & processing expertise.


Steven Bennett, PHD
Founder, Chief Scientific Officer

A leading expert in cannabinoid research, processing and product development, Dr. Bennett is a molecular biologist with a background in neurodegenerative disease, opiate receptors and melanoma. He holds two patents and four provisional patents and has published a series of peer-reviewed papers. Dr. Bennett has a PhD in Molecular Medicine from the University of South Florida College of Medicine and a BS in Biochemistry from Eckerd College. 



Previously, Patrick sharpened his sales skills with a number of leading tech companies in Chicago. From frontline sales, managing sales teams, to even creating sales processes used by hundreds of sales people, he brings a wide array of sales skills and experience to the team. Patrick has a BS in Communications from the University of Missouri.


Michael Hammer
Chief of Staff

Michael previously worked in the higher education space, where he helped leading universities and academic medical centers leverage technology to manage change, optimize organizational design, and improve service delivery. Michael has a BSM in Finance and a BA in Latin American Studies from Tulane University.



Drawing from his background in cultivation and concentrate production, Glenn has worked in the development of novel extraction and post processing techniques for over 7 years, along with supporting facility design and waste reduction planning. Most recently, Glenn worked with the Department of Health to prepare a state-compliant processing and formulations lab in Massachusetts.


John Streicher, PhD
Scientific Director

Dr. Streicher has a range of research experience, with current research focus on signal transduction and molecular pharmacology at the opioid and cannabinoid receptors. He is an assistant professor in the Department of Pharmacology in the College of Medicine at the University of Arizona. Dr. Streicher has degrees from George Fox University, Oregon Health and Science University, and the University of California Los Angeles.


Darryl Hudson, phd

Dr. Hudson has extensive research experience in cultivation, extraction, formulation and analytical testing. He has consulted globally on aspects of the cannabis sector and is widely published in diverse fields, including plant biology/genetics, DNA repair, epigenetics, cancer and cannabis. Dr. Hudson earned his PhD at the University of Guelph.



Dr. Boyd is a faculty research instructor within the Rocky Mountain Alzheimer’s Disease Center Laboratory of Dr. Huntington Potter and within the Department of Neurology and the Institute for Down Syndrome at The University of Colorado. Blending his scientific and business acumen, Dr. Boyd holds science degrees from the University of South Florida and is nearing completion of his MBA from the University of Colorado.


Dustin Mahon

Dustin specializes in the extraction, formulation and infusion of high potency cannabinoid-based medicines. He founded his first legal hydrocarbon extraction company, BETTER Concentrates in 2012. Since then, he has gone on to found one of Colorado’s and, at the time, the world’s largest processing facilities, EC labs (Endocanna/BETTER Concentrates). Dustin has been influential in local, state and national codes and regulations by frequently touring and training regulatory officials. He has won 20+ awards in the industry.  



Dr. Price is an Assistant Clinical Professor in the Division of Emergency Medicine through the Department of Internal Medicine at McMaster University. For the past eight years, he has been a leader in the clinical application of natural pain solutions and Cannabinoid therapeutics. Dr. Price is a Fellow of the Royal College of Physicians and Surgeons trained in Emergency Medicine and has an MD from McMaster University.